BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fundora Ramos MI, Maden LB, Casanova FO, Cruz FH, Reyes CS, Gato AH, Lyncon IB, González EV, Morales KP, Lence JJ, Sanz E. Oncoxin-Viusid® may improve quality of life and survival in patients with hormone-refractory prostate cancer undergoing onco-specific treatments. Mol Clin Oncol 2021;14:5. [PMID: 33235733 DOI: 10.3892/mco.2020.2167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Pandiella A, Sanz E, Díaz-Rodríguez E. Ocoxin oral solution demonstrates antiviral properties in cellular models. Exp Ther Med 2021;22:1127. [PMID: 34504579 DOI: 10.3892/etm.2021.10561] [Reference Citation Analysis]